Copyright
©The Author(s) 2025.
World J Clin Oncol. Aug 24, 2025; 16(8): 107009
Published online Aug 24, 2025. doi: 10.5306/wjco.v16.i8.107009
Published online Aug 24, 2025. doi: 10.5306/wjco.v16.i8.107009
Figure 1 Progression free survival and overall survival based on the sequence of immune checkpoint inhibitor in non-small cell lung cancer patients with brain metastases receiving brain radiotherapy.
A: Progression free survival; B: Overall survival. ICI: Immune checkpoint inhibitor; PFS: Progression free survival; OS: Overall survival.
- Citation: Liu XJ, Ge H, Yuan CL. Survival benefits of concurrent immune checkpoint inhibitor and radiotherapy in non-small cell lung cancer with brain metastases. World J Clin Oncol 2025; 16(8): 107009
- URL: https://www.wjgnet.com/2218-4333/full/v16/i8/107009.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i8.107009